European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours.
Kos-Kudła B, Castaño JP, Denecke T, Grande E, Kjaer A, Koumarianou A, de Mestier L, Partelli S, Perren A, Stättner S, Valle JW, Fazio N.
J Neuroendocrinol. 2023 Dec;35(12):e13343. doi: 10.1111/jne.13343. Epub 2023 Oct 25.
Nonfunctional pancreatic neuroendocrine tumors.
Kuo JH, Lee JA, Chabot JA.
Surg Clin North Am. 2014 Jun;94(3):689-708. doi: 10.1016/j.suc.2014.02.010. Epub 2014 Apr 13.
Sporadic nonfunctional pancreatic neuroendocrine tumors: Risk of lymph node metastases and aggressiveness according to tumor size: A multicenter international study.
Perinel J, Nappo G, Zerbi A, Heidsma CM, Nieveen van Dijkum EJM, Han HS, Yoon YS, Satoi S, Demir IE, Friess H, Vashist Y, Izbicki J, Muller AC, Gloor B, Sandini M, Gianotti L, Subtil F, Adham M.
Surgery. 2022 Sep;172(3):975-981. doi: 10.1016/j.surg.2022.04.013. Epub 2022 May 24.
CT-Radiomic Approach to Predict G1/2 Nonfunctional Pancreatic Neuroendocrine Tumor.
Zhao Z, Bian Y, Jiang H, Fang X, Li J, Cao K, Ma C, Wang L, Zheng J, Yue X, Zhang H, Wang X, Madabhushi A, Xu J, Jin G, Lu J.
Acad Radiol. 2020 Dec;27(12):e272-e281. doi: 10.1016/j.acra.2020.01.002. Epub 2020 Feb 6.
Proteogenomic characterization of non-functional pancreatic neuroendocrine tumors unravels clinically relevant subgroups.
Ji S, Cao L, Gao J, Du Y, Ye Z, Lou X, Liu F, Zhang Y, Xu J, Shi X, Wang H, Li P, Li Y, Chen H, Yang Z, Gao S, Zhang W, Huang D, Ni S, Wei M, Wang F, Wang Y, Ding T, Jing D, Fan G, Gong Z, Lu R, Qin Y, Chen J, Xu X, Wang P, Zhang B, Ding L, Robles AI, Rodriguez H, Chang DK, Hruban RH, Gao D, Gao D, Jin G, Zhou H, Wu J, Yu X.
Cancer Cell. 2025 Apr 14;43(4):776-796.e14. doi: 10.1016/j.ccell.2025.03.016. Epub 2025 Apr 3.
Venous tumor thrombus in nonfunctional pancreatic neuroendocrine tumors.
Balachandran A, Tamm EP, Bhosale PR, Katz MH, Fleming JB, Yao JC, Charnsangavej C.
AJR Am J Roentgenol. 2012 Sep;199(3):602-8. doi: 10.2214/AJR.11.7058.
Neoadjuvant 177Lu-DOTATATE for non-functioning pancreatic neuroendocrine tumours (NEOLUPANET): multicentre phase II study.
Partelli S, Landoni L, Bartolomei M, Zerbi A, Grana CM, Boggi U, Butturini G, Casadei R, Salvia R, Falconi M.
Br J Surg. 2024 Aug 30;111(9):znae178. doi: 10.1093/bjs/znae178.
Nonfunctional Pancreatic Neuroendocrine Tumors: Advances in Diagnosis, Management, and Controversies.
Dumlu EG, Karakoç D, Özdemir A.
Int Surg. 2015 Jun;100(6):1089-97. doi: 10.9738/INTSURG-D-14-00204.1. Epub 2015 Jan 15.
Sporadic pancreatic neuroendocrine tumor: Surgery of the primary tumor.
Deguelte S, de Mestier L, Hentic O, Cros J, Lebtahi R, Hammel P, Kianmanesh R.
J Visc Surg. 2018 Dec;155(6):483-492. doi: 10.1016/j.jviscsurg.2018.08.010. Epub 2018 Nov 15.
Predicting Aggressive Behavior in Nonfunctional Pancreatic Neuroendocrine Tumors With Emphasis on Tumor Size Significance and Survival Trends: A Population-Based Analysis of 1787 Patients.
Fathi AH, Romanyshyn J, Barati M, Choudhury U, Chen A, Sosa JA.
Am Surg. 2020 May;86(5):458-466. doi: 10.1177/0003134820919730.
